BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCatalystFeed//bcf//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioCatalystFeed LXRX catalysts
X-WR-CALDESC:Scheduling/reference data from public records\; dates can move
 . Not investment\, legal or medical advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:6ffddd515ad6a903714f@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20270101
DTEND;VALUE=DATE:20270102
SUMMARY:LXRX P3 readout (est.): SONATA-HCM
DESCRIPTION:A Study to Evaluate the Efficacy and Safety of Sotagliflozin in
  Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy\n
 NCT06481891 | PHASE3 | ACTIVE_NOT_RECRUITING | sponsor: Lexicon Pharmaceut
 icals\nPrimary completion date (ESTIMATED)\; top-line results usually foll
 ow later.\nDate precision: month (shown on the first day)\nTicker LXRX (co
 nfidence 0.9)\nSource: https://clinicaltrials.gov/study/NCT06481891\nSched
 uling/reference data from public records\; dates can move. Not investment\
 , legal or medical advice.
TRANSP:TRANSPARENT
URL:https://clinicaltrials.gov/study/NCT06481891
CATEGORIES:readout,ESTIMATED
END:VEVENT
END:VCALENDAR
